Altimmune, Inc. (ALT)

Altimmune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	478	604	809	364	373	29
Market Cap Growth	247.05%	-25.25%	122.16%	-2.42%	1186.84%	60.73%
Enterprise Value	296	407	624	174	157	-8
PE Ratio	-	-6.83	-9.55	-3.75	-7.61	-1.38
PS Ratio	1165.56	1418.90	-11892.15	82.54	45.58	5.00
PB Ratio	2.76	3.11	4.36	1.83	1.65	0.64
P/FCF Ratio	-9.92	-7.97	-12.89	-4.03	-10.81	-3.02
P/OCF Ratio	-9.92	-7.97	-12.92	-4.65	-10.87	-3.02
EV/Sales Ratio	721.50	954.45	-9172.83	39.38	19.19	-1.43
EV/EBITDA Ratio	-5.88	-4.62	-7.39	-1.80	-2.91	0.41
EV/EBIT Ratio	-5.82	-4.60	-7.35	-1.79	-2.88	0.40
EV/FCF Ratio	-7.42	-5.36	-9.95	-1.92	-4.55	0.86
Quick Ratio	16.09	16.39	10.85	10.44	18.35	9.76
Current Ratio	16.55	17.26	11.31	11.17	19.16	10.04
Asset Turnover	0.00	0.00	0	0.02	0.05	0.10
Interest Coverage	-2727.44	-2526.06	-10612.75	-19417.00	-5779.86	-9169.51
Return on Equity (ROE)	-54.20%	-52.00%	-44.00%	-43.30%	-35.90%	-39.90%
Return on Assets (ROA)	-49.50%	-47.30%	-40.00%	-39.70%	-30.90%	-35.30%
Return on Capital (ROIC)	-58.38%	-49.42%	-47.35%	-48.67%	-24.26%	-47.15%
Earnings Yield	-19.41%	-14.63%	-10.48%	-26.67%	-13.15%	-72.35%
FCF Yield	-15.22%	-12.55%	-7.75%	-24.82%	-9.25%	-33.13%
Buyback Yield / Dilution	-41.25%	-13.47%	-13.67%	-61.03%	-95.33%	-368.35%
Total Shareholder Return	-41.25%	-13.47%	-13.67%	-61.03%	-95.33%	-368.35%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).